Literature DB >> 19307088

Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls.

Katy A L Darvall1, Rachel C Sam, Donald J Adam, Stanley H Silverman, Christopher D Fegan, Andrew W Bradbury.   

Abstract

BACKGROUND: Uncontrolled studies suggest that patients with chronic venous ulceration (CVU) have an increased prevalence of thrombophilia, similar to that observed in patients with deep vein thrombosis. This study compared the nature and prevalence of thrombophilia in patients with varicose veins (VV, CEAP clinical [C] grade C(2) to C(3)) and patients with CVU (C(5) to C(6)) with an age- and sex-matched population without clinical or duplex ultrasound evidence of venous disease.
METHODS: Twenty-seven patients with VV, 27 patients with CVU, and 54 age- and sex-matched case controls with no clinical or duplex evidence of lower limb venous disease, underwent testing for factor V Leiden and prothrombin 20210A mutations, antithrombin deficiencies, and levels of antiphospholipid antibodies, homocysteine, protein C and S, and factor VIII, IX, and XI.
RESULTS: The overall prevalences of single and multiple thrombophilias were significantly higher in cases than in controls. Specifically, in VV patients, the prevalences of no, single, and multiple thrombophilias were 33%, 52%, and 15%, respectively, compared with 63%, 26%, and 11% in VV controls. In CVU patients, the prevalences of no, single, and multiple thrombophilias was 26%, 30%, and 44%, respectively, compared with 66%, 22%, and 11% in CVU controls. Compared with controls, only factor XI levels were significantly higher in VV patients, and homocysteine and factor VIII, IX, and XI levels were all significantly higher in CVU patients.
CONCLUSION: Patients with VV, and particularly CVU, have significantly higher prevalences of single and multiple thrombophilias than age- and sex-matched controls without clinical or duplex evidence of lower limb venous disease. These data support the hypothesis that thrombophilia predisposes to the development of superficial and deep lower limb venous reflux, and so VV and CVU, through the increased occurrence of clinical and subclinical thrombosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307088     DOI: 10.1016/j.jvs.2008.12.017

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Clinical and Genetic Determinants of Varicose Veins.

Authors:  Eri Fukaya; Alyssa M Flores; Daniel Lindholm; Stefan Gustafsson; Daniela Zanetti; Erik Ingelsson; Nicholas J Leeper
Journal:  Circulation       Date:  2018-12-18       Impact factor: 29.690

2.  Complicated lower extremity wound caused by immune thrombocytopenic purpura leading to hypercoagulable state: a team approach for limb salvage.

Authors:  Richard Simman; John Haluschak; Sarah Jackson
Journal:  J Am Col Certif Wound Spec       Date:  2010-09-09

3.  Hyperhomocysteinaemia and chronic venous ulcers.

Authors:  Stefano de Franciscis; Giovambattista De Sarro; Paola Longo; Gianluca Buffone; Vincenzo Molinari; Domenico M Stillitano; Luca Gallelli; Raffaele Serra
Journal:  Int Wound J       Date:  2013-02-19       Impact factor: 3.315

4.  Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study.

Authors:  M Cushman; P W Callas; J O Denenberg; E G Bovill; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-05-21       Impact factor: 5.824

5.  Biological findings from the PheWAS catalog: focus on connective tissue-related disorders (pelvic floor dysfunction, abdominal hernia, varicose veins and hemorrhoids).

Authors:  Lyubov E Salnikova; Maryam B Khadzhieva; Dmitry S Kolobkov
Journal:  Hum Genet       Date:  2016-04-28       Impact factor: 4.132

6.  Venous thromboembolism and varicose veins share familial susceptibility: a nationwide family study in Sweden.

Authors:  Bengt Zöller; Jianguang Ji; Jan Sundquist; Kristina Sundquist
Journal:  J Am Heart Assoc       Date:  2014-08-26       Impact factor: 5.501

7.  Preventing leg ulcer recurrence.

Authors:  Vijay Langer
Journal:  Indian Dermatol Online J       Date:  2014-10

8.  Plasma levels of leucocyte elastase-generated cross linked fibrin degradation products (E-XDP) are elevated in chronic venous disease.

Authors:  Helen Sinabulya; Angela Silveira; Lena Blomgren; Joy Roy
Journal:  PLoS One       Date:  2021-12-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.